Therefore, while HepG2 cells still die after high APAP exposure (Manov et al
among those, stronger evidence exists for metabolic disorders, allergies, autoimmune diseases, disturbances of the central nervous system, and some forms of cancer (Fitzgibbon and Mills 2020)
The lawsuit asserts that because of this failure Plaintiff was and still is caused to suffer from severe gastrointestinal issues, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain, and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications, and fear of developing any of the above-named health consequences. In a statement to CNN for their article Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues by Jamiel Lynch and Jamie Gumbrecht, Novo Nordisk claimed: Patient safety is of utmost importance to Novo Nordisk
It's inert, safe from microbial growth, and resistant to degradation
Eur J Clin Invest 24 : 733736
